investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Decision Models to Compare Treatments in Older Patients with AML
Martine Extermann
3 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Javier Adachi
Identification of the Gastro-Intestinal Microbiota in Patients with Leukemia at MD Anderson, in Texas and INEN, Peru
Leukaemia
Hematology and hematologic malignancies
Karin L Gaensler
Efficacy and Safety of Novel CD80 IL15 IL15Ra Expressing Autologous AML Vaccines
Leukaemia
Hematology and hematologic malignancies
Rainer F Storb
Hematopoietic Chimerism after Stem Cell Allografts
Leukaemia
Hematology and hematologic malignancies
William E Evans
Pharmacogenomics of Childhood Leukemia (ALL)
Leukaemia
Hematology and hematologic malignancies
Richard Aplenc
Genetic Predictors of AML Treatment Response
Leukaemia
Hematology and hematologic malignancies
Roland B Walter
Prediction of Treatment-Related Mortality and Therapeutic Resistance in AML
Leukaemia
Hematology and hematologic malignancies
Reuben Kapur
Role of p21 Activated Kinase in Leukemogenesis
Leukaemia
Hematology and hematologic malignancies
Richard Aplenc
Toxicity Monitoring on Phase III Trials with Administrative Data
Leukaemia
Hematology and hematologic malignancies
Marina Y Konopleva
Hypoxia-Selective Kinase Inhibitors for Leukemia Therapy
Leukaemia
Hematology and hematologic malignancies
